Research view
Switch to patient viewPsoriasis: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- IL-17 12
- IL-23 6
- STAT3 0
- TNF 5
- JAK 1
- GLP-1 5
- TYK2 1
- PI3K 0
- NLRP3 0
- IL-6 0
- IL-1 0
- AKT 0
- MAPK 0
- PDE4 1
- NRF2 0
- PD-1 0
- PPAR 0
- STING 0
- mTOR 0
- TLR4 0
- AMPK 0
- ERK 0
- GIP 1
- VEGF 0
- MMP-9 0
- PD-L1 0
- COX-2 0
- HIF-1 0
- IL-4 0
- SIRT1 0
- TP53 0
- APOE 0
- CGRP 0
- IL-13 0
- KEAP1 0
- LAG-3 0
- PCSK9 0
- PKM2 0
- SGLT2 0
- TSLP 0
- AR 0
- BCL-2 0
- BDNF 0
- BRD4 0
- CD123 0
- CD19 0
- CD40 0
- CSF1R 0
- CTLA-4 0
- CTNNB1 0
- CXCR4 0
- EGFR 0
- EZH2 0
- FTO 0
- G6PD 0
- GPRC5D 0
- HMGB1 0
- HSP90 0
- IDH 0
- JNK 0
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-ERC
Unmasking Non-Genetic Determinants Instructing Tumor Initiation (IGNITE)
European Commission (Horizon Europe) · HORIZON-ERC-POC
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Dissolving microneedle array patch-based psoriatic immunotherapy using nanoparticles (MAPiT)
European Commission (Horizon Europe) · HORIZON-ERC-POC
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
Spatio-temporal integration of skin inflammation (4D-SkINFLAM)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-RIA
DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. (METHYLOMIC)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-RIA
European Commission (Horizon 2020) · RIA
Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States (HIPPOCRATES)
9 of 9 running projects, newest first. Listed amounts together: €31.3m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 28
- Mendelian Randomization Analysis 38
- CRISPR-Cas Systems 4
- Gene Expression Profiling 66
- Sequence Analysis, RNA 6
- Exome Sequencing 5
- Proteomics 24
- Metabolomics 13
- Flow Cytometry 11
- Immunohistochemistry 24
- Xenograft Model Antitumor Assays 1
- Positron-Emission Tomography 1
- Magnetic Resonance Imaging 23
- Machine Learning 27
- Deep Learning 4
- Cohort Studies 63
- Genome-Wide Association Study 38
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.